Domov › Ulcerativni kolitis › New York › New York City

Klinične študije za Ulcerativni kolitis v New York City, NY

23 študij za Ulcerativni kolitis išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Vključevanje udeležencevFaza 2

New York Gastroenterology Associates - Upper East Side /ID# 281767, New York

Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Vključevanje udeležencevFaza 1

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
NYP/Weill Cornell Medical Center, New York

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT03816345

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Vključevanje udeležencevFaza 3

New York Gastroenterology Associates ( Site 0253), New York

Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06651281

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Vključevanje udeležencevFaza 2

Pioneer Clinical Research NY, New York

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06598943

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Vključevanje udeležencevFaza 4

New York Gastroenterology Associates, New York

Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Vključevanje udeležencevFaza 2

Site 037, New York

Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07012395

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Vključevanje udeležencevFaza 3

Inflammatory Bowel Disease Center at NYU Langone, New York
Icahn School of Medicine at Mount Sinai, New York
Weill Cornell Medical College, New York
in še 2

Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Vključevanje udeležencevFaza 2/3

Columbia University Medical Center, New York

Starost 2–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Vključevanje udeležencevFaza 3

Icahn School of Medicine at Mount Sinai, New York
New York Gastroenterology Associates, New York

Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Vključevanje udeležencevFaza 3

Icahn School of Medicine at Mount Sinai, New York

Starost 2–19 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT04844606

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Vključevanje udeležencevFaza 4

NYU Langone Health, New York
Weill Cornell Medical College- New York Presbyterian Hospital, New York

Starost 18–65 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Vključevanje udeležencevFaza 3

Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
New York Gastroenterology Associates - Site Number: 8400009, New York

Starost 16–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Vključevanje udeležencevFaza 3

New York Gastroenterology Associates, New York

Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07577856

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Vključevanje udeležencevFaza 2

Fink Children's Ambulatory Care Center, New York
Kimmel Pavilion - NYU Langone, New York
NYU Grossman School of Medicine, New York
in še 4

Starost 2–11 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07470879

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Vključevanje udeležencevFaza 2

Columbia University Medical Center, New York

Starost 18–80 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Vključevanje udeležencevFaza 3

Manhattan Clinical Research, LLC - Site Number: 8400069, New York
NYU Langone Health - Site Number: 8400091, New York
Weill Cornell Medical College - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
in še 2

Starost 16–80 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07184996